The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Looks like Mr Lucas and family have been adding. Just under 17 million by my calculations.
https://www.provexis.com/shareholder-information/major-shareholders/
Good thing about By-Health being "the first to eat crabs" with the application for the "new function declaration and product registration application is that there is obviously no backlog.
Both the new function health claim (helping maintain normal platelet aggregation function and benefit blood flow health) and the registration for products (Blue Cap) are conducted in a joint review and done simultaneously, hopefully jumping the queue over other Blue Cap registrations that maybe waiting for approval.
Still got no idea how long the whole process will take but IMO it will be quicker than some think.
The press release.
https://www.prnasia.com/story/416412-1.shtml
Translated by Google
"The entire research and development lasted nearly eight years and invested tens of millions of funds."
Translated by Babelfish
"The entire research and development lasted nearly eight years and tens of millions of dollars were invested."
Which one is right, if any, who knows.
The official By-Health version.
https://www-prnasia-com.translate.goog/story/416412-1.shtml?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
"On August 29, the second day after the "Implementation Rules" were officially implemented, BY-HEALTH, the industry leader, took the lead in submitting the application for the new function of health food "helping to maintain normal platelet aggregation function and beneficial to blood flow health", becoming The first company in the industry to submit new function declarations and product registration applications.
The reason why BY-HEALTH was able to submit the innovation application at the first time was that BY-HEALTH had aimed at the new function of "maintaining normal platelet aggregation function" as early as 2015, and used Fruitflow, a water-soluble tomato concentrate known as "natural aspirin". ® (Hytonin), to carry out the research and development of the new function of maintaining normal platelet aggregation. The entire research and development lasted nearly eight years and invested tens of millions of funds."
The new functions of health food are opened up and innovations are applied for, By-health takes the lead.
https://www-eeo-com-cn.translate.goog/2023/0829/603245.shtml?_x_tr_sch=http&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
Unless we made fantastic profit on the €550k of stock we purchased then I still expect further funds will be required when it comes to manufacturing new stock. As for the stock that remains with DSM, It would make sense, to me anyway, that they hold onto it and pay us when they use any for the premix and market ready solutions side of things. In turn we pay them a small warehousing fee. Surly that would be easier than shipping it to us only to ship it back when they need it.
BWTFDIK. :)